AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 25, 2023
Regular, short snoozes keep our brains young by preserving volume, a quality linked with healthy cognitive functions and a lower risk of dementia and other diseases.
BioSpace
JUNE 25, 2023
A year after treatment, Vertex’s VX-880 has eliminated the need for insulin injections in two Type 1 diabetes patients in a Phase I/II clinical trial of its investigational stem cell-based therapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 25, 2023
The Department of Pharmaceuticals (DoP) has rejected review applications filed by the Maharashtra-based Bharat Serums and Vaccines Ltd against National Pharmaceutical Pricing Authority (NPPA) fixing the ceiling price of its infertility treatment drug brand Hucog HP, since the company did not file the petition within the prescribed time limit.
BioSpace
JUNE 25, 2023
The company is dropping its GLP-1 receptor agonist candidate lotiglipron after it induced elevations in liver enzymes in patients treated with the investigational drug.
JAMA Internal Medicine
JUNE 25, 2023
This case-control study examines mortality and causes of death in Swedish patients with nonfunctional adrenal adenomas.
BioSpace
JUNE 25, 2023
Regeneron envisions new dosing for Eylea's label and it's the moment of truth for BioMarin's gene therapy for hemophilia A. For that and more, see inside.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
JUNE 25, 2023
New Phase II data, published in the New England Journal of Medicine, showed Lilly’s oral GLP-1 receptor agonist orforglipron induced nearly 15% weight loss in obese and overweight adults.
Drug Patent Watch
JUNE 25, 2023
FERAHEME (ferumoxytol) Covis Patent: 6,599,498 Expiration: Jun 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit… The post Drug Patent Expirations for the Week of June 25, 2023 appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
JUNE 25, 2023
FibroGen takes another hit as its antibody hopeful fails in a second indication. The biopharma says that it is cutting costs to extend its cash runway.
pharmaphorum
JUNE 25, 2023
NHS a laggard on patient outcomes, says think tank Phil.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
JUNE 25, 2023
CMS has stated that it will cover new Alzheimer’s drugs if the therapies are fully approved. But significant financial questions remain.
JAMA Internal Medicine
JUNE 25, 2023
This Viewpoint describes why people need health information that is easy to understand to make informed decisions about health care and why this is necessary to avoid systemic racism.
BioSpace
JUNE 25, 2023
The acquisition of the privately-held company will bring its novel, investigational beta-lactamase inhibitors and other antimicrobials into the Japanese pharma’s pipeline.
Drug Patent Watch
JUNE 25, 2023
This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs… The post Which pharmaceutical companies have the most suspension dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
JUNE 25, 2023
Experts and analysts warn that the short supply of more than a dozen cancer drugs has reached a crisis level, causing significant anxiety and impacting patient care.
Expert insights. Personalized for you.
197 
Let's personalize your content